Avant Diagnostics (AVDX) Out Front in Early Detection and Screening for Ovarian Cancer
Avant Diagnostics (OTC: AVDX) is a leading medical technology company focused on advancing innovative solutions that improve upon the ways we screen for ovarian cancer. AVDX’s energy and resources aim to bring to market innovative diagnostic tests based upon the completion of the human genome sequencing project. The company works at developing a sophisticated screening test for diagnosing ovarian cancer using OvaDx® – a unique large-panel biomarker screening test for this deadly disease. OvaDx is an advanced diagnostic test used specifically for measuring the activation of the immune system in response to ovarian tumor cell development. Patient sera are used…